312 related articles for article (PubMed ID: 26552849)
1. Redox-Responsive Polyphosphoester-Based Micellar Nanomedicines for Overriding Chemoresistance in Breast Cancer Cells.
Ma YC; Wang JX; Tao W; Sun CY; Wang YC; Li DD; Fan F; Qian HS; Yang XZ
ACS Appl Mater Interfaces; 2015 Dec; 7(47):26315-25. PubMed ID: 26552849
[TBL] [Abstract][Full Text] [Related]
2. Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles.
Yu P; Yu H; Guo C; Cui Z; Chen X; Yin Q; Zhang P; Yang X; Cui H; Li Y
Acta Biomater; 2015 Mar; 14():115-24. PubMed ID: 25498306
[TBL] [Abstract][Full Text] [Related]
3. Actively targeted delivery of anticancer drug to tumor cells by redox-responsive star-shaped micelles.
Shi C; Guo X; Qu Q; Tang Z; Wang Y; Zhou S
Biomaterials; 2014 Oct; 35(30):8711-22. PubMed ID: 25002267
[TBL] [Abstract][Full Text] [Related]
4. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice.
Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD
Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307
[TBL] [Abstract][Full Text] [Related]
5. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761
[TBL] [Abstract][Full Text] [Related]
6. Redox-responsive nanoparticles from the single disulfide bond-bridged block copolymer as drug carriers for overcoming multidrug resistance in cancer cells.
Wang YC; Wang F; Sun TM; Wang J
Bioconjug Chem; 2011 Oct; 22(10):1939-45. PubMed ID: 21866903
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin and lapatinib combination nanomedicine for treating resistant breast cancer.
Wang H; Li F; Du C; Wang H; Mahato RI; Huang Y
Mol Pharm; 2014 Aug; 11(8):2600-11. PubMed ID: 24405470
[TBL] [Abstract][Full Text] [Related]
8. Reversal of paclitaxel resistance in human ovarian cancer cells with redox-responsive micelles consisting of α-tocopheryl succinate-based polyphosphoester copolymers.
Chen FQ; Zhang JM; Fang XF; Yu H; Liu YL; Li H; Wang YT; Chen MW
Acta Pharmacol Sin; 2017 Jun; 38(6):859-873. PubMed ID: 28260803
[TBL] [Abstract][Full Text] [Related]
9. Redox-responsive star-shaped magnetic micelles with active-targeted and magnetic-guided functions for cancer therapy.
Tang Z; Zhang L; Wang Y; Li D; Zhong Z; Zhou S
Acta Biomater; 2016 Sep; 42():232-246. PubMed ID: 27373437
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin-loaded redox-responsive micelles based on dextran and indomethacin for resistant breast cancer.
Zhou Y; Wang S; Ying X; Wang Y; Geng P; Deng A; Yu Z
Int J Nanomedicine; 2017; 12():6153-6168. PubMed ID: 28883726
[TBL] [Abstract][Full Text] [Related]
11. A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy.
Shen W; Liu W; Yang H; Zhang P; Xiao C; Chen X
Biomaterials; 2018 Sep; 178():706-719. PubMed ID: 29433753
[TBL] [Abstract][Full Text] [Related]
12. Aminoglucose-functionalized, redox-responsive polymer nanomicelles for overcoming chemoresistance in lung cancer cells.
Zhou Y; Wen H; Gu L; Fu J; Guo J; Du L; Zhou X; Yu X; Huang Y; Wang H
J Nanobiotechnology; 2017 Nov; 15(1):87. PubMed ID: 29179722
[TBL] [Abstract][Full Text] [Related]
13. Redox-responsive polyphosphate nanosized assemblies: a smart drug delivery platform for cancer therapy.
Liu J; Pang Y; Huang W; Zhu Z; Zhu X; Zhou Y; Yan D
Biomacromolecules; 2011 Jun; 12(6):2407-15. PubMed ID: 21557536
[TBL] [Abstract][Full Text] [Related]
14. Overcoming multidrug resistance by intracellular drug release and inhibiting p-glycoprotein efflux in breast cancer.
Mao J; Qiu L; Ge L; Zhou J; Ji Q; Yang Y; Long M; Wang D; Teng L; Chen J
Biomed Pharmacother; 2021 Feb; 134():111108. PubMed ID: 33341670
[TBL] [Abstract][Full Text] [Related]
15. Polyphosphoester-based nanoparticles with viscous flow core enhanced therapeutic efficacy by improved intracellular drug release.
Ma YC; Wang JX; Tao W; Qian HS; Yang XZ
ACS Appl Mater Interfaces; 2014 Sep; 6(18):16174-81. PubMed ID: 25188541
[TBL] [Abstract][Full Text] [Related]
16. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells.
Wang J; Qu H; Jin L; Zeng W; Qin L; Zhang F; Wei X; Lu W; Zhang C; Liang W
J Pharm Sci; 2011 Jun; 100(6):2267-77. PubMed ID: 21246559
[TBL] [Abstract][Full Text] [Related]
17. Redox-Responsive Core-Cross-Linked Block Copolymer Micelles for Overcoming Multidrug Resistance in Cancer Cells.
Maiti C; Parida S; Kayal S; Maiti S; Mandal M; Dhara D
ACS Appl Mater Interfaces; 2018 Feb; 10(6):5318-5330. PubMed ID: 29355017
[TBL] [Abstract][Full Text] [Related]
18. Disulfide cross-linked polyurethane micelles as a reduction-triggered drug delivery system for cancer therapy.
Yu S; Ding J; He C; Cao Y; Xu W; Chen X
Adv Healthc Mater; 2014 May; 3(5):752-60. PubMed ID: 24574261
[TBL] [Abstract][Full Text] [Related]
19. Redox-responsive polymeric micelles formed by conjugating gambogic acid with bioreducible poly(amido amine)s for the co-delivery of docetaxel and MMP-9 shRNA.
Kang Y; Lu L; Lan J; Ding Y; Yang J; Zhang Y; Zhao Y; Zhang T; Ho RJY
Acta Biomater; 2018 Mar; 68():137-153. PubMed ID: 29288085
[TBL] [Abstract][Full Text] [Related]
20. Restoration of chemosensitivity by multifunctional micelles mediated by P-gp siRNA to reverse MDR.
Shen J; Wang Q; Hu Q; Li Y; Tang G; Chu PK
Biomaterials; 2014 Oct; 35(30):8621-34. PubMed ID: 25002258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
